|
|
|
|
The Florida Department of Health announces a public meeting of the Florida Biomedical Research Advisory Council. The meeting will take place on June 10, 2013 in Orlando, Florida.
|
|
|
|
|
|
Dr. John H. Armstrong, Florida’s Surgeon General, held a
public Symposium on Florida's System for Cancer Research & Collaboration on April 19, 2013 in Tallahassee, FL.
|
|
|
|
|
|
Dr. John H. Armstrong, Florida’s Surgeon General, has named 26 recipients of biomedical research grants totaling $8.05 million for projects scheduled to begin July 1, 2012.
|
|
|
|
|
|
Mayo Clinic Florida researchers have identified a single gene that promotes initial development of the most common form of lung cancer and its lethal metastases.
|
|
|
|
|
|
In the warm waters off Craig Key, Bankhead-Coley grantee,
Dr. Hendrik Luesch, a University of Florida College of Pharmacy Associate Professor, is snorkeling for algae. Researchers say the Gulf of Mexico is filled with a hidden treasure — treasure that could help cure deadly diseases.
|
|
|
|
|
|
Although it's widely accepted that inflammation is a critical underlying factor
in a range of diseases, including the progression of cancer, little is known about its role when normal cells become tumor cells. Now, scientists from the Florida campus of The Scripps Research Institute have shed new light
on exactly how the activation of a pair of inflammatory signaling pathways leads to the transformation of normal breast cells to cancer cells.
|
|
|
|
|
|
The National Institute on Drug Abuse (NIDA), the National Cancer Institute (NCI), the National Institute of Environmental Health Sciences (NIEHS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Mental Health (NIMH), and the National Institute of Neurological Disorders and Stroke (NINDS), in conjunction with other IC partners, intends to publish a Funding Opportunity Announcement (FOA) to establish Centers for tobacco regulatory science to conduct programs of multidisciplinary research that will aid the development and evaluation of tobacco product regulations.
|
|
|
|
|
|
Today there is one FDA-approved drug for stroke, and the patient has to reach the hospital within three hours for it to be effective. Only two-four percent of stroke victims arrive in time. Dr. Keith Pennypacker’s team at University of South Florida is working to change these statistics.
|
|
|
|
|
|
The Florida Department of Health is pleased to present the
Florida Biomedical Research Programs' 2011 Annual Reports. The James and Esther King Biomedical Research Program and the Bankhead-Coley Cancer Research Program offer grants through merit-based competitions to eligible Florida scientists conducting research into tobacco-related diseases and cancer.
|
|
|
|
|
|
Dr. W. Jarrard Goodwin, head and neck cancer (HNC) surgeon at Sylvester Cancer Center, is Project Director of a Bankhead-Coley 2009 Grant that represents an unprecedented partnership between researchers and physicians in Florida to treat and understand cancers associated with the throat and mouth.
|
|
|
|
|
|
Lung cancer is the #1 cause of cancer-related death in Florida, and an estimated 17,150 Florida patients will receive a new diagnosis of lung and bronchus cancer this year.
|
|
|
|
|
|
Floridians say State Must be a Leader in Science and Research
WASHINGTON—October 27, 2011—A majority of Floridians (87%) believe it is important for their state to be a leader in science and medical research, according to a new state poll commissioned by Research!America.
|
|
|
|
|
|
TALLAHASSEE – State Surgeon General Dr. Frank Farmer today applauds the development of Florida’s first Health Disparities Research Agenda. The Agenda was created by a partnership with the Florida Department of Health’s (DOH’s) Office of Minority Health, the Florida Center for Universal Research to Eradicate Disease (FL CURED), and the Biomedical Research Advisory Council (BRAC) in coordination with 31 of the state’s top health disparities researchers and outlines a research plan intent upon achieving health equity for all Floridians.
|
|
|
|
|
|
Triple negative breast cancer affects some 30,000 women yearly in the U.S., with a predominant effect on young women and those of African descent, and is the most challenging type of breast cancer to treat.
|
|
|
|
|
|
Dr. Michael Blaber, 2011 recipient of a King Program Technology Transfer Feasibility Grant at Florida State University, described his team’s work to deliver improved treatments to patients with ischemic disease - a condition where blood vessels do not provide enough blood flow to support healthy tissue.
|
|
|
|
|
|
Ovarian cancer is known as the silent killer due to lack of clear symptoms and the absence of a reliable screening test. More than 70 percent of women are diagnosed after the disease has spread beyond the ovary, and the five-year survival rate is less than 40 percent.
|
|
|
|
|
|
Dr. Hendrik Luesch, 2010 Bankhead-Coley Program, Research Project Grant recipient and other researchers
at University of Florida have modified a toxic chemical produced by tiny marine microbes and successfully deployed it against laboratory models of colon cancer.
|
|
|
|
|
|
The Florida Department of Health (DOH) announces 17 recipients of biomedical research Bridge grants totaling $2.8 million for projects scheduled to begin September 1, 2011.
In making these award determinations, Dr. Frank Farmer, Florida’s Surgeon General accepted funding recommendations made by Florida’s Biomedical Research Advisory Council.
|
|
|
|
|
|
Dr. Frank Farmer, Florida’s Surgeon General, has named 18 initial recipients of biomedical research grants totaling $10.2 million for projects scheduled to begin July 1, 2011.
|
|
|
|
|
|
Dr. Chris Armishaw, 2010 New Investigator Research (NIR) Grantee
at Torrey Pines Institute for Molecular Studies has been working on drug compounds to block nicotine cravings.
|
|
|
|
|
|
Dr. Nasreen Najmunnisa, 2009 RC1 grantee at University of Florida, is developing novel methods for diagnosing and treating Non-Small Cell Lung Cancer (NSLC), which accounts for more deaths than prostate, breast, and colon cancer combined.
|
|
|
|
|
|
Dr. Daniel Paris, 2008 King Program Small Business Technology Transfer grantee at Roskamp Institute, has filed a patent for his identification of a protein, derived from the brain of Alzheimer’s patients, that can stop tumor growth and blood vessel development in models of lung and breast tumors.
|
|
|
|
|
|
The Florida Department of Health Office of Public Health Research is pleased to present the
Florida Biomedical Research Programs legislatively-mandated 2010 annual reports. These programs fund highly meritorious research by offering tobacco-related and cancer research grants to eligible Florida researchers on a competitive basis.
|
|
|
|
|
|
Florida currently ranks number two in the country in bladder cancer, the costliest cancer to treat. Dr. Vinata Lokeshwar, translational researcher and 2008 Bankhead-Coley Program Bridge Grant recipient from the University of Miami, is developing more accurate, less invasive ways to determine how aggressive a patient's tumor is.
|
|
|
|
|
|
Dr. Roman Manetsch, 2007 James & Esther King Program New Investigator Research (NIR) grantee and chemist at University of South Florida, has created a discovery method shortcutting drug discovery.
|
|
|
|
|
|
